Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Pyridine | HCID 1049 | — |
| Reactant | Potassium Carbonate | HCID 11430 | — |
| Reactant | Aripiprazole | HCID 60795 | — |
| Reactant | Decanoyl chloride | HCID 66982 | — |
| Reactant | Ethyl oxoacetate | HCID 70211 | — |
| Catalyst | Tetrabutylammonium Bromide | HCID 74236 | — |
| Solvent | Methanol | HCID 887 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | HCID 58096630 | HCID 58096630 | 38% |
Reaction Steps
A mixture of Aripiprazole (2.0 g, 4.5 mmol), ethyl glyoxylate (50% soln. in toluene, 2.7 mL), K2CO3 (0.49 g, 3.6 mmol), tetrabutylammonium bromide (0.57 g, 1.8 mmol) and dichloromethane (20 mL) was heated at reflux for 4 h. The reaction mixture was cooled and quickly washed with water, dried over MgSO4 and filtered. The resulting solution was treated with pyridine (1.8 mL, 22.2 mmol) and then decanoylchloride (4.6 mL, 22.2 mmol). After being stirred for 3 h, methanol (1 mL) was added and stirred a further 10 min. The reaction mixture was washed with sat. NaHCO3 (aq), dried over MgSO4 and evaporated. The residue was purified on silica eluting with 1:1:0.1 dichloromethane/ethyl acetate/methanol to give the title compound as a yellow oil (1.2 g, 38%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08431576B2 |
|---|
| Source dataset | uspto-grants-2013_04 |
|---|
| ORD ID | ord-3618d60f270b4965b67036fd9f485cfa |
|---|
| Source note | uspto-grants-2013_04 |
|---|